Totowa, N.J.-based Vital Signs pulls in about $250 million in annual sales of devices for respiratory care, anesthesiology and patient monitoring. The company has more than 1,000 workers and a manufacturing operation in Shenzhen, China, according to a press release.
“The acquisition of Vital Signs doubles the size of our specialty disposables business and transforms it into an industry leader by adding global scale and a new call point in anesthesia. We are in a better position to serve customers in this large, global and growing market with a broader product portfolio and complementary expertise in respiratory and anesthesia care,” CareFusion chairman & CEO Kieran Gallahue said in prepared remarks.
The deal was originally announced in mid-November. San Diego-based CareFusion put $100 million on a 40% stake in Israel-based Caesarea Medical Electronics in early December.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.